The Pharmacy Times® Attention-Deficit Hyperactivity Disorder (ADHD) Resource Center is a comprehensive resource for clinical news and expert insights on issues related to ADHD, a chronic condition that can cause attention difficulty, hyperactivity, and impulsiveness.
February 21st 2025
In a study of 5 different drugs, amlodipine was the only one to reduce hyperactivity in patients with attention-deficit hyperactivity disorder (ADHD).
October 29th 2024
Biomarkers in the Brain May Predict ADHD Diagnosis With 99% Accuracy
July 21st 2021Specific communication among different brain regions, known as brain connectivity, could potentially serve as a biomarker for attention-deficit hyperactivity disorder (ADHD), according to a study published in Frontiers in Physiology.
Read More
Pharmacogenomics: The Future of ADHD Treatment Options
December 6th 2019Studying individuals’ genomes can help influence how different medications work for a patient, avoid harmful adverse drug reactions, and allow scientists to develop personalized medicines for patients with a wide range of diseases and disorders.
Read More
Analysis Suggests Stimulant Treatment Prevents Some Outcomes of ADHD
August 6th 2019An analysis of previous studies of children and young adults with ADHD has quantified the extent to which stimulant treatment reduces the development of mood disorders, problems in school, conduct disorders, substance use disorders, and other problems.
Read More